
Shareholding9 Sept 2026, 08:00 pm
Sudarshan Pharma: Hemal Mehta Releases 20 Lakh Equity Shares Pledge
AI Summary
Sudarshan Pharma Industries Ltd has filed a revised disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. Promoter Hemal Vasantrai Mehta has released the pledge on 20,00,000 equity shares of the company. This action pertains to the release of encumbrance on shares held by the promoter. The disclosure was made on September 9, 2026, following an email from the exchange dated September 4, 2026.
Key Highlights
- Promoter Hemal Vasantrai Mehta released pledge on 20 lakh equity shares.
- Disclosure filed under SEBI (SAST) Regulations, 2011.
- Action relates to release of encumbrance on promoter's shares.
- Revised disclosure submitted on September 9, 2026.
Price Impact
More from SUDARSHAN